Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IBD metabonomics predicts phenotype, disease course, and treatment response.

EBioMedicine - 1 Sept 2021

Bjerrum Jacob T, Wang Yulan L, Seidelin Jakob B, Nielsen Ole H

Abstract excerpt

Metabonomics in inflammatory bowel disease (IBD) characterizes the effector molecules of biological systems and thus aims to describe the molecular phenotype, generate insight into the pathology, and predict disease course and response to treatment. Nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and integrated NMR and MS platforms coupled with multivariate analyses have been applied to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Gut microbiota and health
Share to Inflammatory Bowel Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammatory Bowel Diseases

Share to Liver Disease Diagnosis and Treatment

Share to Metabolome

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 34419930
DOI: 10.1016/j.ebiom.2021.103551
PMCID: PMC8379620

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IBD metabonomics predicts phenotype, disease course, and treatment response.PMID 34419930Read ↗

Proteomics and metabolomics in inflammatory bowel disease.Semantic proximity Read ↗

Exploring the utility of metabolic profiling in stratifying patient groups in Inflammatory Bowel DiseaseSemantic proximity Read ↗

Deciphering the microbiome–metabolome landscape of an inflammatory bowel disease inception cohortSemantic proximity Read ↗

Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s DiseaseSemantic proximity Read ↗

A distinct serum metabolic signature outperforms C-reactive protein as a non-invasive marker for monitoring disease activity in Inflammatory Bowel DiseaseSemantic proximity Read ↗

Systematic Mining of gut microbiota biomarkers for IBDSemantic proximity Read ↗

Multi-omics in Crohn's disease: New insights from insideSemantic proximity Read ↗

Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitisSemantic proximity Read ↗

Targeted 1H NMR metabolomics and immunological phenotyping of human fresh blood and serum samples discriminate between healthy individuals and inflammatory bowel disease patients treated with anti-TNF.Semantic proximity Read ↗

Identifying Robust Biomarkers for the Diagnosis and Subtype Distinction of Inflammatory Bowel Disease through Comprehensive Serum Metabolomic ProfilingSemantic proximity Read ↗

Identifying robust biomarkers for the diagnosis and subtype distinction of inflammatory bowel disease through comprehensive serum metabolomic profilingSemantic proximity Read ↗

Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.